Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 29;28(1):287.
doi: 10.3390/molecules28010287.

Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative Agents

Affiliations

Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative Agents

Riccardo Barbari et al. Molecules. .

Abstract

A current trend of research in the health field is toward the discovery of multifunctional compounds, capable of interacting with multiple biological targets, thus simplifying multidrug therapies and improving patient compliance. The aim of this work was to synthesize new multifunctional chemical entities bearing a benzothiazole nucleus, a structure that has attracted increasing interest for the great variety of biological actions that it can perform, and already used as a scaffold in several multifunctional drugs. Compounds are reported, divided into two distinct series, synthetized and tested in vitro for the antioxidant, and include UV-filtering and antitumor activities. DPPH and FRAP tests were chosen to outline an antioxidant activity profile against different radical species. The UV-filtering activity was investigated, pre- and post-irradiation, through evaluation of a O/W sunscreen standard formulation containing 3% of the synthetic compounds. The antitumor activity was investigated both on human melanoma cells (Colo-38) and on immortalized human keratinocytes as a control (HaCat). A good antiproliferative profile in terms of IC50 was chosen as a mandatory condition to further investigate apoptosis induction as a possible cytotoxicity mechanism through the Annexin V test. Compound BZTcin4 was endowed with excellent activity and a selectivity profile towards Colo-38, supported by a good antioxidant capacity and an excellent broad-spectrum photoprotective profile.

Keywords: antioxidant; antitumor; benzothiazole derivatives; multifunctional; organic sunscreen UV-filter.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structures of PBSA (lead UVB-filter) and some of its derivatives.
Scheme 1
Scheme 1
Synthesis of compounds BZTidr1–6. Reagents and conditions: (a) N2H4·H2O, EtOH, 1 h, reflux; (b) Ar-CHO, EtOH, 3–8 h, reflux.
Scheme 2
Scheme 2
Synthesis of compounds BZTcin1–5. Reagents and conditions: (c) EDC·HCl, HOBt, CH3CN, overnight, 55–60 °C.
Figure 2
Figure 2
Effect of benzothiazole derivatives on selected cell lines: (panel A) HaCaT cell line; (panel B) melanoma Colo-38 cell line. Each compound was tested at two different concentrations approaching their IC50 value with the Annexin V assay. Triton X-100 was utilized as a positive control (data not shown).
Figure 2
Figure 2
Effect of benzothiazole derivatives on selected cell lines: (panel A) HaCaT cell line; (panel B) melanoma Colo-38 cell line. Each compound was tested at two different concentrations approaching their IC50 value with the Annexin V assay. Triton X-100 was utilized as a positive control (data not shown).

References

    1. Bansal Y., Silakari O. Multifunctional compounds: Smart molecules for multifactorial diseases. Eur. J. Med. Chem. 2014;76:31–42. doi: 10.1016/j.ejmech.2014.01.060. - DOI - PubMed
    1. Makhoba X.H., Viegas J.C., Mosa R.A., Viegas F.P.D., Pooe O.J. Potential impacti of the multi-target drug approach in the treatment of some complex diseases. Drug Des. Devel. Ther. 2020;14:3235–3249. doi: 10.2147/DDDT.S257494. - DOI - PMC - PubMed
    1. Eisen S.A., Miller D.K., Woodward R.S., Spitznagel E., Przybeck T.R. The effect of prescribed daily dose frequency on patient medication compliance. Arch. Intern. Med. 1990;150:1881–1884. doi: 10.1001/archinte.1990.00390200073014. - DOI - PubMed
    1. Keith C.T., Borisy A.A., Stockwell B.R. Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 2005;4:71–78. doi: 10.1038/nrd1609. - DOI - PubMed
    1. Hohl C.M., Dankoff J., Colacone A., Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann. Emerg. Med. 2001;38:666–671. doi: 10.1067/mem.2001.119456. - DOI - PubMed